Abstract: Compositions and methods for preventing or treating a disease or a disorder associated with dyslipidemia are provided. This includes prevention or treatment of non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH). The method comprises administering an effective amount of RRx-001, or a pharmaceutically acceptable salt thereof, to the subject in need thereof to reduce at least one factor of the disease or the disorder, such as a hepatic steatosis score, a serum ALT level, a fibrosis marker, a serum AST level, a hepatic level of cholesterol, a hepatic level of triglycerides, insulin resistance, hyperinsulinemia, a serum NLRP3 level, an oxidative or inflammatory stress marker in the subject, and/or a marker associated with low-density lipoprotein (LDL). In some embodiments, the effective amount of RRx-001, or the pharmaceutically acceptable salt thereof, is administered in a pharmaceutical composition that includes a blood product and/or an agent.

Abstract: Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Abstract: The disclosure describes the use of compositions comprising ghrelin or ghrelin variant to improve dose intensity, dose frequency, duration of use, reduced toxicity, and/or patient compliance of chemotherapeutic agents.

Abstract: Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Abstract: Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Abstract: Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Abstract: Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Abstract: Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Abstract: Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Abstract: Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Abstract: A communications system includes a source, a destination, and multiple relays. In a first time period, the source emits a first transmission and a first relay retransmits a prior source transmission. Then, in a second, subsequent time period, the source node emits a second transmission and a second relay transmits the source transmission from the first time period. Optionally, the transmission from the second relay also includes the message from the first relay during the first time period. Similarly, in a third time period, the first relay transmits a message that includes the second relay's transmission and the second source transmission from the second time period. Alternatively, the source node transmit in a first frequency band, the first and second relays receive only in the first frequency band, and retransmit in a second frequency band, and the destination receives in both the first and second frequency bands.

Abstract: Various example embodiments are disclosed relating to relay networks or multi-hop networks, and also relating to power control and channel reuse techniques for wireless relay networks. A technique of power control in a wireless relay network may include receiving a channel measurement report via a relay station from a mobile station attached to the relay station, and determining a mobile station-specific downlink data transmission power level for the relay station to transmit data to the mobile station based at least in part on the received channel measurement report from the mobile station.

Abstract: Modified E1a regulatory sequences are provided, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Also provided are modified E1a sequences that selectively express particular isoforms. Also provided is an E1b-19K clone insertion site. These modified sequences can be used individually, or in combination with one another, to provide tumor-selective expression of proteins.

Abstract: A system for transmitting data over a MIMO channel has a transmitter and a receiver. In the transmitter, the input data is encoded over at least two pipes by a concatenation of at least two constituent signal-space encoders. Each constituent encoder is used to generate, in response to the input data, a sequence of symbols from a channel alphabet having at least one dimension. Each symbol of the channel alphabet includes at least one complex symbol having real and imaginary coordinates. The transmitter interleaves the coordinates of the sequence of channel alphabet symbols, and transmits (from at least two transmit antennas) the interleaved coordinates. Preferably, each constituent encoder maximizes a minimum coordinate-wise Hamming distance between members of all valid pairs of symbol sequences, maximizes a minimum Euclidean distance between members of all valid pairs of different codewords, and obeys an equal eigenvalue criterion.

Abstract: A process for forming a pouch having an evacuated headspace containing a flowable material is disclosed. The process includes the steps of: providing a continuous tube of flexible and sealable film; supplying the continuous tube with a predetermined amount of flowable material; pinching the continuous tube above a sealing region so as to form a pinched portion of the continuous tube; evacuating the headspace between the pinched portion and the predetermined amount of flowable material; and sealing the continuous tube at the sealing region to form a top seal of a previously formed pouch containing flowable material and a bottom seal of a next-to-be filled pouch. Also disclosed is a vertical form-fill-seal apparatus for forming a pouch containing a flowable material and having an evacuated headspace.

Abstract: A network entity in a multi-transmit antenna system, such as a transmitting or receiving entity, includes a component such as a pre-coder or a receiver, and is configured for full-spatial-rate coding data. The network entity is capable of providing a full-spatial-rate codebook having been designed by selecting an underlying partial-spatial-rate codebook designed for a system configured for partial-spatial-rate coding data. The full-spatial-rate codebook can then be designed in a manner including defining the full-spatial-rate codewords based upon partial-spatial-rate codewords of the partial-spatial rate codebook and basis vectors of a null space of the respective partial-spatial-rate codewords in a multidimensional vector space. The network entity can also be capable of selecting codewords of the codebook in accordance with a sub-space tracking method whereby the codewords of the codebook can be selected in a manner that exploits correlations therebetween.

Abstract: A process for forming a pouch having an evacuated headspace containing a flowable material is disclosed. The process includes the steps of: providing a continuous tube of flexible and sealable film; supplying the continuous tube with a predetermined amount of flowable material; pinching the continuous tube above a sealing region so as to form a pinched portion of the continuous tube; evacuating the headspace between the pinched portion and the predetermined amount of flowable material; and sealing the continuous tube at the sealing region to form a top seal of a previously formed pouch containing flowable material and a bottom seal of a next-to-be filled pouch. Also disclosed is a vertical form-fill-seal apparatus for forming a pouch containing a flowable material and having an evacuated headspace.

Abstract: Fast fading in cellular systems causes time variation of the Channel Impulse Response (CIR) resulting in significant performance degradation that is reduced by adding a pulse train to the transmitted data symbols and estimating the CIR by averaging the symbols as they vary from one OFDM symbol to another within the physical data frame (or packet).

Abstract: An apparatus for applying pressure to a body part comprising: a first sleeve comprising a multiplicity of pressure-applying resilient protrusions configured to apply a therapeutic pressure to a surface of the body part of a patient; and a second sleeve slidably received over the first sleeve, the second sleeve configured to apply a pressure to the first sleeve, thereby increasing the therapeutic pressure applied by the first sleeve on the limb.

Abstract: A communications system includes a source, a destination, and multiple relays. In a first time period, the source emits a first transmission and a first relay retransmits a prior source transmission. Then, in a second, subsequent time period, the source node emits a second transmission and a second relay transmits the source transmission from the first time period. Optionally, the transmission from the second relay also includes the message from the first relay during the first time period. Similarly, in a third time period, the first relay transmits a message that includes the second relay's transmission and the second source transmission from the second time period. Alternatively, the source node transmit in a first frequency band, the first and second relays receive only in the first frequency band, and retransmit in a second frequency band, and the destination receives in both the first and second frequency bands.